DR. ERIC SCOTT SCHAEFER M.D. NPI 1558325118

NPI Details

DR. Eric Scott Schaefer, M.D. is a hematology and oncology internal medicine in Fayetteville, AR with 23 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Eric Scott Schaefer, M.D. NPI is 1558325118. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL COLLEGE OF OHIO
Graduation Year:2003

The provider's business location address is:

3232 N NORTHHILLS BLVD
FAYETTEVILLE, AR
ZIP 72703-005
Phone: (479) 587-1700
Fax: (479) 587-1366

The NPI 1558325118 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, durvalumab, 10 mg (HCPCS:J9173)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Phosphate level (HCPCS:84100)
• Magnesium level (HCPCS:83735)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Bilirubin level, direct (HCPCS:82248)
• Uric acid level, blood (HCPCS:84550)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Ct scan of chest with contrast (HCPCS:71260)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Ferritin (blood protein) level (HCPCS:82728)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Ct scan of chest without contrast (HCPCS:71250)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Unclassified drugs (HCPCS:J3490)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Mri scan of brain before and after contrast (HCPCS:70553)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Blood test, clotting time (HCPCS:85610)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Blood creatinine level (HCPCS:82565)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Vitamin d-3 level (HCPCS:82306)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• X-ray of chest, 2 views (HCPCS:71046)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Drawing of blood for a medical problem (HCPCS:99195)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Folic acid level, serum (HCPCS:82746)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, furosemide, up to 20 mg (HCPCS:J1940)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Mri scan of abdomen before and after contrast (HCPCS:74183)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month (HCPCS:98980)
• Ct scan of head or brain before and after contrast (HCPCS:70470)
• Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie (HCPCS:A9596)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Ct scan of soft tissue of neck without contrast (HCPCS:70490)
• Limited ultrasound scan of abdomen (HCPCS:76705)
• Ultrasound study of one arm or leg veins with compression and maneuvers (HCPCS:93971)

The enumeration date for this NPI number is 4/12/2006 and was last updated on 3/30/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.